Lanean...

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure

Prevention and treatment strategies for heart failure (HF) in diabetes have not been fully established, at least partly due to lack of recognition of a pathological link between the two and effective antidiabetic agents for HF. Recent cardiovascular (CV) outcomes trials demonstrated that treatment w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cardiovasc Diabetol
Egile Nagusiak: Tanaka, Atsushi, Node, Koichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968589/
https://ncbi.nlm.nih.gov/pubmed/29801492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0719-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!